During the past decade, Osp. S. Giuseppe Fatebenefratelli conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osp. S. Giuseppe Fatebenefratelli" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Dompé Farmaceutici S.p.A" with 2 trials sponsored, "FibroGen" with 1 trials sponsored, "Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy" with 1 trials sponsored and "Istituto Nazionale per lo Studio e la Cura dei Tumori" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Osp. S. Giuseppe Fatebenefratelli" are "Idiopathic Pulmonary Fibrosis" (5 trials), "Lung Cancer" (2 trials), "Bladder Cancer" (1 trials), "Dry Eye" (1 trials) and "Dry Eye Disease" (1 trials). Many other conditions were trialed in "Osp. S. Giuseppe Fatebenefratelli" in a lesser frequency.

Most popular intervention types in "Osp. S. Giuseppe Fatebenefratelli" are "Drug" (10 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nintedanib" (3 trials), "Oxervate" (2 trials), "Placebo" (2 trials), "Vehicle" (2 trials) and "BIBF 1120" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osp. S. Giuseppe Fatebenefratelli" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Osp. S. Giuseppe Fatebenefratelli". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Osp. S. Giuseppe Fatebenefratelli, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osp. S. Giuseppe Fatebenefratelli, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".